Drugs that contain Acetaminophen
1. Acetaminophen patents expiration
ACETAMINOPHEN's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8741959 | FRESENIUS KABI USA | Paracetamol for parenteral administration |
Apr, 2030
(5 years from now) | |
Market Authorisation Date: 28 October, 2015
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
ACETAMINOPHEN family patents
2. Ofirmev patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6028222 | MALLINCKRODT HOSP | Stable liquid paracetamol compositions, and method for preparing same |
Aug, 2017
(6 years ago) | |
|
US6028222 (Pediatric) | MALLINCKRODT HOSP | Stable liquid paracetamol compositions, and method for preparing same |
Feb, 2018
(6 years ago) | |
| US6992218 | MALLINCKRODT HOSP | Method for obtaining aqueous formulations of oxidation-sensitive active principles |
Jun, 2021
(2 years ago) | |
|
US6992218 (Pediatric) | MALLINCKRODT HOSP | Method for obtaining aqueous formulations of oxidation-sensitive active principles |
Dec, 2021
(2 years ago) | |
| US9987238 | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
Nov, 2028
(4 years from now) | |
| US10383834 | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
Nov, 2028
(4 years from now) | |
| US9610265 | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
Nov, 2028
(4 years from now) | |
|
US9987238 (Pediatric) | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
May, 2029
(5 years from now) | |
|
US9610265 (Pediatric) | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
May, 2029
(5 years from now) | |
| US9399012 | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
Sep, 2031
(7 years from now) | |
|
US9399012 (Pediatric) | MALLINCKRODT HOSP | Reduced dose intravenous acetaminophen |
Mar, 2032
(7 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-196) | Jan 27, 2020 |
| Pediatric Exclusivity(PED) | Jul 27, 2020 |
| New Product(NP) | Nov 02, 2013 |
Market Authorisation Date: 02 November, 2010
Treatment: Modified dosing regimen for the management of mild to moderate pain or management of moderate to severe pain as an adjunct to opioid analgesics; Modified dosing regimen for the management of mild to m...
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of OFIRMEV before it's drug patent expiration?
More Information on Dosage
OFIRMEV family patents